Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia

29 Dec 2008

Abstract excerpt

Endothelial progenitor cells (EPCs) are a subset of the total mononuclear cell population (tMNCs) that possess an enhanced potential for differentiation within the endothelial-cell lineage. Typically, EPCs are selected from tMNCs via the expression of both hematopoietic stem-cell markers and endothelial-cell markers, such as CD34, or by culturing tMNCs in media selective for endothelial cells. Both EPCs and tMNCs...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis and VEGF in Cancer
Share to Congenital heart defects research
Share to Mesenchymal stem cell research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19115244
DOI: 10.1002/jcp.21672

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemiaPMID 19115244Read ↗

Biologic properties of endothelial progenitor cells and their potential for cell therapy.Semantic proximity Read ↗

Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.Semantic proximity Read ↗

Endothelial progenitor cells: diagnostic and therapeutic considerationsSemantic proximity Read ↗

Endothelial progenitor cells in cardiovascular diseasesSemantic proximity Read ↗

Endothelial progenitor cells in cell-based therapy for cardiovascular disease.Semantic proximity Read ↗

Stem cell‐derived endothelial cells for cardiovascular disease: a therapeutic perspectiveSemantic proximity Read ↗

Diverse origin and function of cells with endothelial phenotype obtained from adult human blood.Semantic proximity Read ↗

Endothelial Progenitor Cells in Heart Failure: an Authentic Expectation for Potential Future Use and a Lack of Universal Definition.Semantic proximity Read ↗

Endothelial-Regenerating CellsSemantic proximity Read ↗

Vascular repair by endothelial progenitor cells.Semantic proximity Read ↗

In vitro functional comparison of therapeutically relevant human vasculogenic progenitor cells used for cardiac cell therapy.Semantic proximity Read ↗

Endothelial progenitor cells as a new agent contributing to vascular repair.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.